Bluepharma Industria Farmaceutica S.A.

  • Bluepharma
About Bluepharma Industria Farmaceutica S.A.

The Bluepharma Group is today one of the most entrepreneurial and innovative in the pharmaceutical sector, having already achieved remarkable prestige  in the most demanding international markets.

Bluepharma Group offers a set of capabilities from research, pre-formulation, formulation development, up to commercial manufacturing  (including HPAPI), and two sites, including one that is dedicated to High Potent API. Bluepharma also supports non-clinical and clinical stages, including logistics and RA support (IMP, CMC) with a dedicated GMP facility for the handling of high potent APIs covering clinical, registration, and commercial batches

Bluepharma has a large record of accomplishments in development and co-development partnerships. Our range of technologies covers solid dosage forms (IR and ER), polymer-based solutions, solid dispersions (hot-melt extrusion), oral thin films, and complex injectables.  We can give support through all product development stages, including NCE.

  • PT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022

Products from Bluepharma Industria Farmaceutica S.A. (5)

  • Clinical Manufacturing

    Product Clinical Manufacturing

    .Integrated drug development service (CRO/CDMO) including clinical manufacturing and management.
    The range of activities offered by Bluepharma includes:
    - Clinical material cGMP manufacturing
    - Clinical supply management
    - clinical material
    - placebo
    - pac...
  • Complex Sterile Formulations Contract Development

    Product Complex Sterile Formulations Contract Development

    +25 Years of accumulated experience in Lipid and polymer-based formulations.
    Regarding Complex Injectables, Bluepharma's focus is on Lipid-based, polymer-based, and Long-acting injectable (LAI) formulations. Bluepharma allies the scientific expertise with the technical capability to ensure the success of...
  • Drug Delivery Platforms

    Product Drug Delivery Platforms

    Modified release, hot-melt extrusion, ODT, oral thin films, oral sprays, and polymer-based solutions,

    Our range of technologies covers solid dosage forms (IR and ER), polymer-based solutions, solid dispersions (hot-melt extrusion), oral sprays, oral thin films, and complex injectables (LN...
  • High Potent Manufacturing

    Product High Potent Manufacturing

    Manufacturing site dedicated to OSD forms incorporating high potent APIs EOB 4/5 (OEL up to < 0.03 µg/m3).
    Bluepharma has dedicated R&D centers and scale-up facilities that are well equipped in the formulation and pilot-scale equipment as well as analytics (covering a wide range of techniques)...
  • Pharmaceutical development (CDMO) & Exclusive portfolio

    Product Pharmaceutical development (CDMO) & Exclusive portfolio

    From research, pre-formulation, and formulation development, up to commercial manufacturing  (including HPAPI).
    Bluepharma offers an integrated drug development service (CDMO) from research, pre-formulation, and formulation development, up to commercial manufacturing  (i...

Bluepharma Industria Farmaceutica S.A. Resources (2)

  • Brochure Diversified and exclusive portfolio

    Development and Licensing Opportunities.

    Due to our extensive international track record (successfully inspected by FDA, EMA, ANVISA, among others), we collaborate globally with major pharmaceutical companies,  by licensing out our own technology or distributing our own brand worldwide, namely in the United States, Europe, Middle East, APAC, China and LATAM. 
  • Video Bluepharma´s Presentation

    Bluepharma is a Portuguese Group with more 20 years, more than 700 employees and 20 innovative companies that cover all stages of the pharmaceutical industry value chain of the drug, from R&D to the market, imposing itself for the excellence of its production unit, the quality and training of its employees and the experience and dynamism of its management team.